Sandy Shocks ex, Prismatic Evolutions #159
Prismatic Evolutions · #159/180

Sandy Shocks ex

Special Illustration RareFightingBasicexAncient

Sandy Shocks ex from Prismatic Evolutions, card 159 of 180 in the set. Released in January 2025. The card sits in the collector tier of the print and draws active demand in graded condition.

Market price
-USD
Loading recent sales…
Grade in app
PSA 10PSA 9Raw NM
HP
220
Type
Fighting
Stage
Basic / ex / Ancient
Pokédex
-
About this card

Sandy Shocks ex · Prismatic Evolutions, what to know.

About the Sandy Shocks ex card

Sandy Shocks ex sits at #159 in Prismatic Evolutions, released in January 2025. Prismatic Evolutions is part of the modern English Pokémon TCG era and uses the standard contemporary card frame and rarity tiers.

Print variants and how to spot them

Prismatic Evolutions shipped in Holofoil, Reverse Holo, ex, Full Art, and Special Illustration. The set is Eeveelution-focused, with new ex versions and Special Illustration Rares for each member of the Eevee family. Umbreon ex SIR is the headline chase.

Grading and condition

For graded buyers, modern cards have cleaner cardstock than the Wizards-era prints, so the grading bar is higher. A PSA 10 on a modern holo or alt-art requires close to flawless centering and pristine surface. PSA 9 populations are large; PSA 10 populations on the marquee chases (Special Illustration Rares, alt arts) are the cards that actually move price. Submission math favors clear PSA 10 candidates and stays away from PSA 8 or 9 outcomes.

If you are buying this card

If you are buying this card, the order of operations is rarity tier first, then condition. Confirm whether you are looking at the standard holo, an alt art / Special Illustration variant, or a Hyper Rare; the price spread between tiers is often 10x or more. For raw purchases on chase-tier modern cards, insist on photo or video showing the holo surface and edges. Modern cardstock is stiffer than Wizards-era stock but the high pull rates mean PSA 10 supply is large; price your buy against PSA 10 population reports.